Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden
Addiction · 2026
DOI: 10.1111/add.70238 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Addiction, 2026. Verfasst von Devy L Elling und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Hospitalization, Alcoholism, Alcohol Deterrents, Alcohol-Related Disorders. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Alcohol Retail Monopoly Alcohol Research Council.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Aim
To examine the socioeconomic differences in the effectiveness of alcohol use disorders (AUD) pharmacotherapy and risk of AUD hospitalisation.
Design
A prospective register‐based cohort study.
Setting
Sweden.
Participants
Individuals who were registered as living in Sweden in 2005 (16–64 years) with a first‐time AUD diagnosis and complete information on their socioeconomic position (SEP) between 2005 and 2019 ( n = 148 626). Measurement The outcome was AUD hospitalisation. The use of AUD pharmacotherapy was treated as a time‐varying exposure. SEP was the moderator. The association between the joint‐exposure (pharmacotherapy use and SEP) and AUD hospitalisation was assessed using a competing‐risk regression model, adjusted for sociodemographic factors, previous mental health diagnoses and use of other psychiatric medications.
Findings
Pharmacotherapy use was associated with a lower risk of AUD hospitalisation among high SEP individuals [subdistribution hazard ratio (SHR) = 0.83, 95% confidence interval (CI) = 0.77–0.90], but not among those with low SEP (SHR = 1.02, 95% CI = 0.94–1.10) and middle SEP (SHR = 1.01, 95% CI = 0.94–1.09), compared with low SEP individuals when not using pharmacotherapy.
Conclusions
In Sweden, alcohol use disorder (AUD) pharmacotherapy appears to be effective to reduce the risk of AUD hospitalisation only among individuals of high socioeconomic position.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
- Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
- Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Devy L Elling, Daniel Falkstedt
Förderung
- Swedish Alcohol Retail Monopoly Alcohol Research Council
Zitieren
APA
Elling, D. L., Thern, E., Mangot-Sala, L., Tiihonen, J., Hammarberg, A., Falkstedt, D., & Taipale, H. (2026). Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden. Addiction. https://doi.org/10.1111/add.70238
Vancouver
Elling DL, Thern E, Mangot-Sala L, Tiihonen J, Hammarberg A, Falkstedt D, et al. Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden. Addiction. 2026. doi:10.1111/add.70238
BibTeX
@article{Elling2026,
author = {Elling, Devy L and Thern, Emelie and Mangot-Sala, Lluís and Tiihonen, Jari and Hammarberg, Anders and Falkstedt, Daniel and Taipale, Heidi},
title = {Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70238}
}
EUVIMED